Technology News and Research

RSS

ThromboGenics receives IWT grant to study potential new biotherapeutics for DME

ThromboGenics NV, an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines for the back of the eye, today announces that it has been awarded a €3 million grant from the Flemish agency for Innovation by Science and Technology.

10 Mar 2014

RIT plans for new school of health and nutrition to promote healthy lifestyles

Rochester Institute of Technology today announced plans for a new school of health and nutrition, charged with educating students on the role of nutrition, exercise and behavior modification in promoting healthy lifestyles.

10 Mar 2014

MedScope's new mobile medical alert system now available

MedScope, the leading developer and marketer of high tech medical alert systems, has announced its new two-way communication mobile Personal Emergency Response System (mPERS), that can be used anywhere, is now available.

10 Mar 2014

Scientists use novel metagenomic approaches to characterize microbial communities that reside in human gut

The gut microbiota contains a vast number of microorganisms from all three domains of life, including bacteria, archaea and fungi, as well as viruses. These interact in a complex way to contribute towards both health and the development of disease - interactions that are only now being elucidated thanks to the application of advanced DNA sequencing technology in this field.

10 Mar 2014

Eye health experts across Commonwealth join forces to combat avoidable blindness

A new -7.1 million grant will enable experts from a range of institutions to come together for the first time as the Commonwealth Eye Health Consortium, coordinated by the International Centre for Eye Health at the London School of Hygiene & Tropical Medicine.

10 Mar 2014

Tissue analysis near tumors holds promise for earlier detection, new treatments

Seemingly healthy cells may in fact hide clues that lung cancer will later develop, according to a study led by researchers at The University of Texas MD Anderson Cancer Center The research is published online in the Journal of the National Cancer Institute.

9 Mar 2014

FDA-approved anti-psychotic drugs possess tumor-killing activity against glioblastoma

Researchers at the University of California, San Diego School of Medicine have discovered that FDA-approved anti-psychotic drugs possess tumor-killing activity against the most aggressive form of primary brain cancer, glioblastoma. The finding was published in this week's online edition of Oncotarget.

8 Mar 2014

Medicaid expansion: With Arkansas 'private' plan authorized for another year, officials now focus on possible fixes

After surviving an effort earlier this week to defund it, supporters of the state's private option are now working on alterations that will smooth its future. Meanwhile, the back-and-forth over whether to pursue the expansion continues in Virginia and Utah.

7 Mar 2014

Neuroscientist hopes to paint fuller picture of minds and bodies in Neuroscape lab

How does an autistic child take in information when he sits in a classroom abuzz with social activity? How long does it take someone with multiple sclerosis, which slows activity in the brain, to process the light bouncing off the windshield while she drives?

7 Mar 2014

Ludwig, Agenus to advance three monoclonal antibody checkpoint modulators into preclinical development

Ludwig Cancer Research and Agenus Inc. today announced the selection of three monoclonal antibody checkpoint modulators (CPMs) that Agenus is advancing into preclinical development.

7 Mar 2014

Ohr Pharmaceutical partners with CSHL to develop trodusquemine and related analogs

Ohr Pharmaceutical, a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, and leading global cancer research center Cold Spring Harbor Laboratory (CSHL) today announced the establishment of DepYmed Inc., a new joint venture to develop trodusquemine and related analogs.

6 Mar 2014

7-Tesla ultra-high-field MRI facilitates more accurate diagnosis of breast cancer, says study

Taking part in a recent study, scientists at the MedUni Vienna have demonstrated for the first time worldwide that 7-Tesla ultra-high-field magnetic resonance imaging (MRI) can be used for clinical applications in patients with breast tumours.

6 Mar 2014

Elsevier launches medical reference and learning platforms for clinicians, students

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of the fully redesigned Expert Consult and Student Consult, its two medical reference and learning platforms, now powered by Inkling, the creator of engaging, intuitive digital books for some of the world's most respected publishers.

6 Mar 2014

Tetraphase Pharmaceuticals reports net loss of $11.3 million for Q4 2013

Tetraphase Pharmaceuticals, Inc. today reported financial results for the quarter and full year ended December 31, 2013.

6 Mar 2014

Safeguard Scientifics reports net income of $24 million for fourth quarter 2013

Safeguard Scientifics, Inc. today announced fourth quarter and full-year 2013 financial results. For the three months ended December 31, 2013, Safeguard's net income was $24.0 million, or $1.10 per share, compared to net loss of $10.8 million, or $0.51 per share for the same period in 2012. For the year ended December 31, 2013, Safeguard's net loss was $35.5 million, or $1.66 per share, compared to $39.4 million, or $1.88 per share for the same period in 2012.

6 Mar 2014

Saffola launches Saffola Total, oil with multi-seed technology

Saffola has recently launched Saffola Total, oil with multi-seed technology which has twice the antioxidant power than olive oil and higher antioxidant power than most oils.

6 Mar 2014

Debiopharm plans to expand, optimize activities at Martigny manufacturing facility

Debiopharm Group, a Swiss-based global biopharmaceutical group of companies active in drug development, GMP manufacturing of proprietary drugs, diagnostics, and investments, has announced its decision to expand and optimize activities at Debiopharm Research & Manufacturing S.A., its industrial development and production facility in Martigny (Valais, Switzerland), through acquisition of industrial high-value added activities or companies in the pharmaceutical, biotech or medtech field.

6 Mar 2014

ASTRO white paper recommends specific guidance to follow in the delivery of HDR brachytherapy

The American Society for Radiation Oncology has issued a new white paper, "A review of safety, quality management, and practice guidelines for high-dose-rate brachytherapy," that recommends specific guidance to follow in the delivery of high-dose-rate (HDR) brachytherapy to improve quality and patient safety, according to the manuscript published in the March-April 2014 print issue of Practical Radiation Oncology, the official clinical practice journal of ASTRO.

6 Mar 2014

New drug is effective against superbug MRSA

"I routinely call hospitals and request their yearly antibiotic susceptibility testing data," said Washington University in St. Louis' Timothy Wencewicz. "The log might say, for example, that they've treated hundreds of patients for Acinetobacter baumanni, a bacterium brought into U.S. hospitals by soldiers wounded in the Iraq war, with 30 different antibiotics.

6 Mar 2014

Scientists reveal how a genetic code variation results in devastating brain diseases

New findings reveal how a mutation, a change in the genetic code that causes neurodegeneration, alters the shape of DNA, making cells more vulnerable to stress and more likely to die.

6 Mar 2014

Technology News and Research

ThromboGenics receives IWT grant to study potential new biotherapeutics for DME

RIT plans for new school of health and nutrition to promote healthy lifestyles

MedScope's new mobile medical alert system now available

Scientists use novel metagenomic approaches to characterize microbial communities that reside in human gut

Eye health experts across Commonwealth join forces to combat avoidable blindness

Tissue analysis near tumors holds promise for earlier detection, new treatments

FDA-approved anti-psychotic drugs possess tumor-killing activity against glioblastoma

Medicaid expansion: With Arkansas 'private' plan authorized for another year, officials now focus on possible fixes

Neuroscientist hopes to paint fuller picture of minds and bodies in Neuroscape lab

Ludwig, Agenus to advance three monoclonal antibody checkpoint modulators into preclinical development

Ohr Pharmaceutical partners with CSHL to develop trodusquemine and related analogs

7-Tesla ultra-high-field MRI facilitates more accurate diagnosis of breast cancer, says study

Elsevier launches medical reference and learning platforms for clinicians, students

Tetraphase Pharmaceuticals reports net loss of $11.3 million for Q4 2013

Safeguard Scientifics reports net income of $24 million for fourth quarter 2013

Saffola launches Saffola Total, oil with multi-seed technology

Debiopharm plans to expand, optimize activities at Martigny manufacturing facility

ASTRO white paper recommends specific guidance to follow in the delivery of HDR brachytherapy

New drug is effective against superbug MRSA

Scientists reveal how a genetic code variation results in devastating brain diseases

Industry Focus eBook - Cell biology (5th edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News